Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.
NASDAQ:PETQ

PetIQ (PETQ) Stock Price, News & Analysis

PetIQ logo

About PetIQ Stock (NASDAQ:PETQ)

Advanced Chart

Key Stats

Today's Range
$30.98
$30.98
50-Day Range
$30.74
$30.99
52-Week Range
$15.09
$31.06
Volume
N/A
Average Volume
480,624 shs
Market Capitalization
$925.99 million
P/E Ratio
79.44
Dividend Yield
N/A
Price Target
$29.67
Consensus Rating
Moderate Buy

Company Overview

PetIQ, Inc. operates as a pet medication and wellness company in the United States and internationally. It operates in two segments, Products and Services. The company offers Rx pet medications, which sells flea and tick control, heartworm preventatives, arthritis, thyroid, diabetes and pain treatments, antibiotics, and other specialty medications; and develops and manufactures its own proprietary value-branded products, as well as third-party branded products for dogs and cats. It also provides OTC medications and supplies primarily within the flea and tick control, dog dewormers, and behavior management categories of the health and wellness industry in various forms, such as spot on (topical) treatments, chewables, oral tablets, and collars. In addition, the company offers health and wellness products that include dog and cat treats, oral health solutions, stain and odor treatments, and pet nutritional supplements under the PetArmor®, Rocco & Roxie®, VetIQ®, Minties® and Sentry® brands. It provides its products primarily under the PetIQ, PetArmor, VIP Petcare, VetIQ PetCare, VetIQ, Capstar, Advecta, SENTRY, Sergeants, PurLuv, Rocco & Roxie, Minties, Heart Shield Plus, and TruProfen brand names. In addition, the company operates veterinarian service platform through community clinics, pop-up locations, wellness centers, and permanent locations that offer cost effective and convenient veterinary wellness services, including diagnostic tests, vaccinations, prescription medications, microchipping, grooming and hygiene, and wellness checks; and provides veterinary care services. It operates through veterinarian, retail, and e-commerce channels. PetIQ, Inc. was founded in 2010 and is headquartered in Eagle, Idaho.

Receive PETQ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for PetIQ and its competitors with MarketBeat's FREE daily newsletter.

PETQ Stock News Headlines

PetIQ Acquired by Bansk Group, Delisted from Nasdaq
PetIQ announces completion of acquisition by Bansk Group
Ignore every stock…
Stocks have been on a tear in 2024… And there’s plenty of great opportunities out there. But one expert says you should forget about EVERY stock for a moment and focus on an even bigger opportunity. The current GOLD supercycle You see, stocks are a dime a dozen for the most part… And, fortunately, they go up more than they go down. But every few decades, precious metals have a systematic supercycle that tends to dwarf the potential of just about anything else. The last time things aligned like this on gold it surged 536%
PetIQ Merges with Bansk Group in $1.5B Deal
PetIQ Inc Class A
See More Headlines

PETQ Stock Analysis - Frequently Asked Questions

PetIQ, Inc. (NASDAQ:PETQ) posted its quarterly earnings data on Wednesday, August, 7th. The company reported $0.70 EPS for the quarter, topping analysts' consensus estimates of $0.50 by $0.20. The firm's quarterly revenue was up 4.6% on a year-over-year basis.

PetIQ (PETQ) raised $86 million in an initial public offering (IPO) on Friday, July 21st 2017. The company issued 5,700,000 shares at a price of $14.00-$16.00 per share. Jefferies and William Blair served as the underwriters for the IPO and Oppenheimer, Raymond James and SunTrust Robinson Humphrey were co-managers.

Based on aggregate information from My MarketBeat watchlists, some other companies that PetIQ investors own include NVIDIA (NVDA), Humana (HUM), Meta Platforms (META), American Water Works (AWK), Broadcom (AVGO), Voyager Therapeutics (VYGR) and TotalEnergies (TTE).

Company Calendar

Last Earnings
8/07/2024
Today
1/21/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Drugs, proprietaries, & sundries
Sub-Industry
Wholesale
Current Symbol
NASDAQ:PETQ
Fax
N/A
Employees
1,933
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$29.67
High Stock Price Target
$31.00
Low Stock Price Target
$28.00
Potential Upside/Downside
-4.2%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
4 Analysts

Profitability

Net Income
$2.13 million
Pretax Margin
1.29%

Debt

Sales & Book Value

Annual Sales
$1.10 billion
Cash Flow
$2.68 per share
Book Value
$7.58 per share

Miscellaneous

Free Float
27,011,000
Market Cap
$925.99 million
Optionable
Optionable
Beta
1.73
10 Best Stocks to Own in 2025 Cover

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2025 and why they should be in your portfolio.

Get This Free Report

This page (NASDAQ:PETQ) was last updated on 1/21/2025 by MarketBeat.com Staff
From Our Partners